trial

Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia

NCTId NCT04637724
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 33 (actual)
Sponsored by Oded Meiron
Primary completion 2023-08-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
33 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2019-11-29
Primary completion
2023-08-30
Eligibility
ALL · 18 Years · 75 Years

Interventions & indications

Drugs
transcranial direct current stimulation (tDCS)

Sponsors

Oded MeironLead Sponsor

Investigators

1
Alex Borochov, MDPrincipal Investigator

Sites

1 total
Jerusalem, Israel

Facts & assertions

4 sourced
Enrollment
33
Phase
NA
Primary Completion Date
2023-08-30
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation (tDCS)
drug
lead_sponsor
Oded Meiron
company
indication
Schizophrenia
indication
Schizo Affective Disorder
indication
Schizophrenia
indication
investigator
Alex Borochov, MD
person